| 000 | 01812 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518071138.0 | ||
| 264 | 0 | _c20201126 | |
| 008 | 202011s 0 0 eng d | ||
| 022 | _a1439-099X | ||
| 024 | 7 |
_a10.1007/s00066-019-01543-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJakob, Jens | |
| 245 | 0 | 0 |
_aImpact of preoperative treatment on the CINSARC prognostic signature: translational research results from a phase 1 trial of the German Interdisciplinary Sarcoma Group (GISG 03). _h[electronic resource] |
| 260 |
_bStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] _cMar 2020 |
||
| 300 |
_a280-285 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 |
_aGermany _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdiagnosis |
| 650 | 0 | 4 |
_aPreoperative Care _xmethods |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSarcoma _xdiagnosis |
| 650 | 0 | 4 |
_aSunitinib _xtherapeutic use |
| 650 | 0 | 4 | _aTranscriptome |
| 650 | 0 | 4 | _aTranslational Research, Biomedical |
| 700 | 1 | _aLesluyes, Tom | |
| 700 | 1 | _aSimeonova-Chergou, Anna | |
| 700 | 1 | _aWenz, Frederik | |
| 700 | 1 | _aHohenberger, Peter | |
| 700 | 1 | _aChibon, Frederic | |
| 700 | 1 | _aLe Guellec, Sophie | |
| 773 | 0 |
_tStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] _gvol. 196 _gno. 3 _gp. 280-285 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00066-019-01543-5 _zAvailable from publisher's website |
| 999 |
_c30318408 _d30318408 |
||